{{copyedit|time=2012-04-05T01:27:26+00:00}}
{{chemref|time=2012-04-05T01:27:26+00:00}}
{{medical}}
{{Drugbox
| verifiedrevid = 460793850
| IUPAC_name = 2,2',2<nowiki>''</nowiki>,2<nowiki>'''</nowiki>-(4,8-di(piperidin-1-yl)pyrimido[5,4-''d'']pyrimidine-2,6-diyl)bis(azanetriyl)tetraethanol
| image = Dipyridamole.svg

<!--Clinical data-->
| tradename = Persantine
| Drugs.com = {{drugs.com|monograph|dipyridamole}}
| MedlinePlus = a682830
| pregnancy_category = B
| legal_UK = POM
| legal_US = Rx-only  
| routes_of_administration = PO, IV

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound = 99%
| metabolism = Hepatic
| elimination_half-life = Alpha (40 mins), Beta (10 Hours)

<!--Identifiers-->
| CASNo_Ref = {{cascite|correct|CAS}}
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 58-32-2
| ATC_prefix = B01
| ATC_suffix = AC07
| PubChem = 3108
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
 | DrugBank = DB00975
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 2997
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 64ALC7F90C
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D00302
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 4653
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 932

<!--Chemical data-->
| C=24 | H=40 | N=8 | O=4 
| molecular_weight = 504.626 [[Gram|g]]/[[Mole_(unit)|mol]]
| smiles = n3c(nc2c(nc(nc2N1CCCCC1)N(CCO)CCO)c3N4CCCCC4)N(CCO)CCO
| InChI = 1/C24H40N8O4/c33-15-11-31(12-16-34)23-26-20-19(21(27-23)29-7-3-1-4-8-29)25-24(32(13-17-35)14-18-36)28-22(20)30-9-5-2-6-10-30/h33-36H,1-18H2
| InChIKey = IZEKFCXSFNUWAM-UHFFFAOYAG
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C24H40N8O4/c33-15-11-31(12-16-34)23-26-20-19(21(27-23)29-7-3-1-4-8-29)25-24(32(13-17-35)14-18-36)28-22(20)30-9-5-2-6-10-30/h33-36H,1-18H2
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = IZEKFCXSFNUWAM-UHFFFAOYSA-N
}}

'''双嘧达莫'''（Dipyridamole，中華藥典名：二吡待摩<ref>中華藥典第六版 554頁</ref>，商品名'''潘生丁'''Persantine），是一种扩张[[冠狀動脉|冠狀動脉]]及抗[[血栓|血栓]]形成的药物。主要用于[[缺血性心脏病|缺血性心脏病]]及[[中风|中风]]，也少量用于其他疾病的治疗。在[[心肌|心肌]][[灌注掃描|灌注掃描]]的壓力相檢測前，也常以此藥靜脈注射增加[[心率|心率]]。

副作用有[[头痛|头痛]]、[[眩晕|眩晕]]、[[噁心|噁心]]、[[嘔吐|嘔吐]]、[[腹泻|腹泻]]等；与肝素合用可引起出血倾向；偶发皮疹、冠状动脉[[盜血|盜血]]现象。

==参考资料==
{{reflist}}

{{Antithrombotics}}
{{Phosphodiesterase inhibitors}}
{{Adenosinergics}}
{{Poisoning and toxicity}}

[[Category:抗血小板药|Category:抗血小板药]]
[[Category:哌啶|Category:哌啶]]
[[Category:中風|Category:中風]]
[[Category:缺血性心脏病|Category:缺血性心脏病]]
[[Category:抗心绞痛药|Category:抗心绞痛药]]
[[Category:磷酸二酯酶抑制剂|Category:磷酸二酯酶抑制剂]]
[[Category:乙胺|Category:乙胺]]